Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
Erythrocyte membrane fluidity and haemoglobin haemoporphyrin conformation: features revealed in patients with heart failure.

Pathophysiology : the official journal of the International Society for Pathophysiology

Rodnenkov OV, Luneva OG, Ulyanova NA, Maksimov GV, Rubin AB, Orlov SN, Chazov EI.
PMID: 15837166
Pathophysiology. 2005 May;11(4):209-213. doi: 10.1016/j.pathophys.2004.12.001.

This study examined the possible involvement of abnormal erythrocyte oxygen (O(2)) transport in the pathogenesis of heart failure. Haemoglobin (Hb) haemoporphyrin conformation was assessed by Raman spectroscopy (RS) of blood samples, whereas membrane fluidity was estimated at depths of...

Cite
Rodnenkov OV, Luneva OG, Ulyanova NA, et al. Erythrocyte membrane fluidity and haemoglobin haemoporphyrin conformation: features revealed in patients with heart failure. Pathophysiology. 2005;11(4):209-213doi: 10.1016/j.pathophys.2004.12.001.
Rodnenkov, O. V., Luneva, O. G., Ulyanova, N. A., Maksimov, G. V., Rubin, A. B., Orlov, S. N., & Chazov, E. I. (2005). Erythrocyte membrane fluidity and haemoglobin haemoporphyrin conformation: features revealed in patients with heart failure. Pathophysiology : the official journal of the International Society for Pathophysiology, 11(4), 209-213. https://doi.org/10.1016/j.pathophys.2004.12.001
Rodnenkov, O V, et al. "Erythrocyte membrane fluidity and haemoglobin haemoporphyrin conformation: features revealed in patients with heart failure." Pathophysiology : the official journal of the International Society for Pathophysiology vol. 11,4 (2005): 209-213. doi: https://doi.org/10.1016/j.pathophys.2004.12.001
Rodnenkov OV, Luneva OG, Ulyanova NA, Maksimov GV, Rubin AB, Orlov SN, Chazov EI. Erythrocyte membrane fluidity and haemoglobin haemoporphyrin conformation: features revealed in patients with heart failure. Pathophysiology. 2005 May;11(4):209-213. doi: 10.1016/j.pathophys.2004.12.001. PMID: 15837166.
Copy Download .nbib Format: NLM
Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial.

Stroke

Bosch J, Lonn EM, Dagenais GR, Gao P, Lopez-Jaramillo P, Zhu J, Pais P, Avezum A, Sliwa K, Chazova IE, Peters RJG, Held C, Yusoff K, Lewis BS, Toff WD, Khunti K, Reid CM, Leiter LA, Yusuf S, Hart RG.
PMID: 33985364
Stroke. 2021 Aug;52(8):2494-2501. doi: 10.1161/STROKEAHA.120.030790. Epub 2021 May 14.

BACKGROUND AND PURPOSE: The HOPE-3 trial (Heart Outcomes Prevention Evaluation–3) found that antihypertensive therapy combined with a statin reduced first stroke among people at intermediate cardiovascular risk. We report secondary analyses of stroke outcomes by stroke subtype, predictors, treatment...

Cite
Bosch J, Lonn EM, Dagenais GR, et al. Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial. Stroke. 2021;52(8):2494-2501doi: 10.1161/STROKEAHA.120.030790.
Bosch, J., Lonn, E. M., Dagenais, G. R., Gao, P., Lopez-Jaramillo, P., Zhu, J., Pais, P., Avezum, A., Sliwa, K., Chazova, I. E., Peters, R. J. G., Held, C., Yusoff, K., Lewis, B. S., Toff, W. D., Khunti, K., Reid, C. M., Leiter, L. A., Yusuf, S., & Hart, R. G. (2021). Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial. Stroke, 52(8), 2494-2501. https://doi.org/10.1161/STROKEAHA.120.030790
Bosch, Jackie, et al. "Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial." Stroke vol. 52,8 (2021): 2494-2501. doi: https://doi.org/10.1161/STROKEAHA.120.030790
Bosch J, Lonn EM, Dagenais GR, Gao P, Lopez-Jaramillo P, Zhu J, Pais P, Avezum A, Sliwa K, Chazova IE, Peters RJG, Held C, Yusoff K, Lewis BS, Toff WD, Khunti K, Reid CM, Leiter LA, Yusuf S, Hart RG. Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial. Stroke. 2021 Aug;52(8):2494-2501. doi: 10.1161/STROKEAHA.120.030790. Epub 2021 May 14. PMID: 33985364.
Copy Download .nbib Format: NLM
[Medicine of the twentieth century. The evolution of diagnosis].

Terapevticheskii arkhiv

Chazov EI.
PMID: 7784966
Ter Arkh. 1995;67(4):19-21.

No abstract available.

Cite
Chazov EI. Meditsina dvadtsatogo veka. Evoliutsiia diagnostiki. [Medicine of the twentieth century. The evolution of diagnosis]. Ter Arkh. 1995;67(4):19-21
Chazov, E. I. (1995). Meditsina dvadtsatogo veka. Evoliutsiia diagnostiki. [Medicine of the twentieth century. The evolution of diagnosis]. Terapevticheskii arkhiv, 67(4), 19-21.
Chazov, E I. "Meditsina dvadtsatogo veka. Evoliutsiia diagnostiki." [Medicine of the twentieth century. The evolution of diagnosis]. Terapevticheskii arkhiv vol. 67,4 (1995): 19-21.
Chazov EI. Meditsina dvadtsatogo veka. Evoliutsiia diagnostiki. [Medicine of the twentieth century. The evolution of diagnosis]. Ter Arkh. 1995;67(4):19-21. Russian. PMID: 7784966.
Copy Download .nbib Format: NLM
[Methodological aspects of the diagnosis of disease].

Vestnik Akademii meditsinskikh nauk SSSR

Chazov EI.
PMID: 7293399
Vestn Akad Med Nauk SSSR. 1981;(4):45-9.

No abstract available.

Cite
Chazov EI. Metodologicheskie aspekty diagnoza zabolevaniia. [Methodological aspects of the diagnosis of disease]. Vestn Akad Med Nauk SSSR. 1981;(4):45-9
Chazov, E. I. (1981). Metodologicheskie aspekty diagnoza zabolevaniia. [Methodological aspects of the diagnosis of disease]. Vestnik Akademii meditsinskikh nauk SSSR, (4), 45-9.
Chazov, E I. "Metodologicheskie aspekty diagnoza zabolevaniia." [Methodological aspects of the diagnosis of disease]. Vestnik Akademii meditsinskikh nauk SSSR vol. ,4 (1981): 45-9.
Chazov EI. Metodologicheskie aspekty diagnoza zabolevaniia. [Methodological aspects of the diagnosis of disease]. Vestn Akad Med Nauk SSSR. 1981;(4):45-9. Russian. PMID: 7293399.
Copy Download .nbib Format: NLM
[Pathogentic features of heart insufficiency in myocardial infarct and method of its treatment].

Terapevticheskii arkhiv

Chazov EI, Zysko AP, Ruds MIa, Iosava KV, Mazur NA, Goncharova LV.
PMID: 6000141
Ter Arkh. 1966 Nov;38(11):52-8.

No abstract available.

Cite
Chazov EI, Zysko AP, Ruds MIa, et al. Patogeneticheskie osobennosti serdechnoĭ nedostatochnostipri infarkte miokarda i metody ee lecheniia. [Pathogentic features of heart insufficiency in myocardial infarct and method of its treatment]. Ter Arkh. 1966;38(11):52-8
Chazov, E. I., Zysko, A. P., Ruds, M. I. a., Iosava, K. V., Mazur, N. A., & Goncharova, L. V. (1966). Patogeneticheskie osobennosti serdechnoĭ nedostatochnostipri infarkte miokarda i metody ee lecheniia. [Pathogentic features of heart insufficiency in myocardial infarct and method of its treatment]. Terapevticheskii arkhiv, 38(11), 52-8.
Chazov, E I, et al. "Patogeneticheskie osobennosti serdechnoĭ nedostatochnostipri infarkte miokarda i metody ee lecheniia." [Pathogentic features of heart insufficiency in myocardial infarct and method of its treatment]. Terapevticheskii arkhiv vol. 38,11 (1966): 52-8.
Chazov EI, Zysko AP, Ruds MIa, Iosava KV, Mazur NA, Goncharova LV. Patogeneticheskie osobennosti serdechnoĭ nedostatochnostipri infarkte miokarda i metody ee lecheniia. [Pathogentic features of heart insufficiency in myocardial infarct and method of its treatment]. Ter Arkh. 1966 Nov;38(11):52-8. Russian. PMID: 6000141.
Copy Download .nbib Format: NLM
[Current problems in the diagnosis of internal diseases].

Terapevticheskii arkhiv

Chazov EI.
PMID: 451917
Ter Arkh. 1979;51(5):3-7.

No abstract available.

Cite
Chazov EI. Sovremennye problemy diagnostiki vnutrennikh bolezneĭ. [Current problems in the diagnosis of internal diseases]. Ter Arkh. 1979;51(5):3-7
Chazov, E. I. (1979). Sovremennye problemy diagnostiki vnutrennikh bolezneĭ. [Current problems in the diagnosis of internal diseases]. Terapevticheskii arkhiv, 51(5), 3-7.
Chazov, E I. "Sovremennye problemy diagnostiki vnutrennikh bolezneĭ." [Current problems in the diagnosis of internal diseases]. Terapevticheskii arkhiv vol. 51,5 (1979): 3-7.
Chazov EI. Sovremennye problemy diagnostiki vnutrennikh bolezneĭ. [Current problems in the diagnosis of internal diseases]. Ter Arkh. 1979;51(5):3-7. Russian. PMID: 451917.
Copy Download .nbib Format: NLM
Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study.

International journal of hypertension

Chazova I, Schlaich MP.
PMID: 23533713
Int J Hypertens. 2013;2013:541689. doi: 10.1155/2013/541689. Epub 2013 Feb 25.

This study was designed to assess the effects of moxonidine on blood pressure and aspects of the metabolic syndrome in racially diverse population of patients encountered in routine medical practice. Physicians collected data on a minimum of three consecutive...

Cite
Chazova I, Schlaich MP. Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study. Int J Hypertens. 2013;2013:541689doi: 10.1155/2013/541689.
Chazova, I., & Schlaich, M. P. (2013). Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study. International journal of hypertension, 2013541689. https://doi.org/10.1155/2013/541689
Chazova, Irina, and Schlaich, Markus P. "Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study." International journal of hypertension vol. 2013 (2013): 541689. doi: https://doi.org/10.1155/2013/541689
Chazova I, Schlaich MP. Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study. Int J Hypertens. 2013;2013:541689. doi: 10.1155/2013/541689. Epub 2013 Feb 25. PMID: 23533713; PMCID: PMC3596898.
Copy Download .nbib Format: NLM
Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial.

Stroke

Bosch J, Lonn EM, Dagenais GR, Gao P, Lopez-Jaramillo P, Zhu J, Pais P, Avezum A, Sliwa K, Chazova IE, Peters RJG, Held C, Yusoff K, Lewis BS, Toff WD, Khunti K, Reid CM, Leiter LA, Yusuf S, Hart RG.
PMID: 33985364
Stroke. 2021 Aug;52(8):2494-2501. doi: 10.1161/STROKEAHA.120.030790. Epub 2021 May 14.

[Figure: see text].

Cite
Bosch J, Lonn EM, Dagenais GR, et al. Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial. Stroke. 2021;52(8):2494-2501doi: 10.1161/STROKEAHA.120.030790.
Bosch, J., Lonn, E. M., Dagenais, G. R., Gao, P., Lopez-Jaramillo, P., Zhu, J., Pais, P., Avezum, A., Sliwa, K., Chazova, I. E., Peters, R. J. G., Held, C., Yusoff, K., Lewis, B. S., Toff, W. D., Khunti, K., Reid, C. M., Leiter, L. A., Yusuf, S., & Hart, R. G. (2021). Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial. Stroke, 52(8), 2494-2501. https://doi.org/10.1161/STROKEAHA.120.030790
Bosch, Jackie, et al. "Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial." Stroke vol. 52,8 (2021): 2494-2501. doi: https://doi.org/10.1161/STROKEAHA.120.030790
Bosch J, Lonn EM, Dagenais GR, Gao P, Lopez-Jaramillo P, Zhu J, Pais P, Avezum A, Sliwa K, Chazova IE, Peters RJG, Held C, Yusoff K, Lewis BS, Toff WD, Khunti K, Reid CM, Leiter LA, Yusuf S, Hart RG. Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial. Stroke. 2021 Aug;52(8):2494-2501. doi: 10.1161/STROKEAHA.120.030790. Epub 2021 May 14. PMID: 33985364.
Copy Download .nbib Format: NLM
Ion transport, membrane fluidity and haemoglobin conformation in erythrocyte from patients with cardiovascular diseases: Role of augmented plasma cholesterol.

Pathophysiology : the official journal of the International Society for Pathophysiology

Luneva OG, Brazhe NA, Maksimova NV, Rodnenkov OV, Parshina EY, Bryzgalova NY, Maksimov GV, Rubin AB, Orlov SN, Chazov EI.
PMID: 17403600
Pathophysiology. 2007 May;14(1):41-6. doi: 10.1016/j.pathophys.2006.12.001. Epub 2007 Apr 02.

Tissue hypoxia, which plays a key role in the development of renal and vascular complications of cardiovascular diseases (CVD), might be considered a consequence of vascular remodeling and/or attenuated oxygen (O(2)) delivery by erythrocytes. Using Raman spectroscopy (RS), we...

Cite
Luneva OG, Brazhe NA, Maksimova NV, et al. Ion transport, membrane fluidity and haemoglobin conformation in erythrocyte from patients with cardiovascular diseases: Role of augmented plasma cholesterol. Pathophysiology. 2007;14(1):41-6doi: 10.1016/j.pathophys.2006.12.001.
Luneva, O. G., Brazhe, N. A., Maksimova, N. V., Rodnenkov, O. V., Parshina, E. Y., Bryzgalova, N. Y., Maksimov, G. V., Rubin, A. B., Orlov, S. N., & Chazov, E. I. (2007). Ion transport, membrane fluidity and haemoglobin conformation in erythrocyte from patients with cardiovascular diseases: Role of augmented plasma cholesterol. Pathophysiology : the official journal of the International Society for Pathophysiology, 14(1), 41-6. https://doi.org/10.1016/j.pathophys.2006.12.001
Luneva, O G, et al. "Ion transport, membrane fluidity and haemoglobin conformation in erythrocyte from patients with cardiovascular diseases: Role of augmented plasma cholesterol." Pathophysiology : the official journal of the International Society for Pathophysiology vol. 14,1 (2007): 41-6. doi: https://doi.org/10.1016/j.pathophys.2006.12.001
Luneva OG, Brazhe NA, Maksimova NV, Rodnenkov OV, Parshina EY, Bryzgalova NY, Maksimov GV, Rubin AB, Orlov SN, Chazov EI. Ion transport, membrane fluidity and haemoglobin conformation in erythrocyte from patients with cardiovascular diseases: Role of augmented plasma cholesterol. Pathophysiology. 2007 May;14(1):41-6. doi: 10.1016/j.pathophys.2006.12.001. Epub 2007 Apr 02. PMID: 17403600.
Copy Download .nbib Format: NLM
May Measurement Month 2017 in Russia: hypertension treatment and control-Europe.

European heart journal supplements : journal of the European Society of Cardiology

Rotar O, Konradi A, Tanicheva A, Nakonechnikov S, Blinova N, Beaney T, Xia X, Poulter NR, Chazova I, Shlyakhto E.
PMID: 31043892
Eur Heart J Suppl. 2019 Apr;21:D101-D103. doi: 10.1093/eurheartj/suz068. Epub 2019 Apr 24.

Elevated blood pressure (BP) is a growing burden worldwide, leading to over 10 million deaths each year. May Measurement Month (MMM) is a global initiative by the International Society of Hypertension aimed at raising awareness of high BP and...

Cite
Rotar O, Konradi A, Tanicheva A, et al. May Measurement Month 2017 in Russia: hypertension treatment and control-Europe. Eur Heart J Suppl. 2019;21:D101-D103doi: 10.1093/eurheartj/suz068.
Rotar, O., Konradi, A., Tanicheva, A., Nakonechnikov, S., Blinova, N., Beaney, T., Xia, X., Poulter, N. R., Chazova, I., & Shlyakhto, E. (2019). May Measurement Month 2017 in Russia: hypertension treatment and control-Europe. European heart journal supplements : journal of the European Society of Cardiology, 21D101-D103. https://doi.org/10.1093/eurheartj/suz068
Rotar, Oxana, et al. "May Measurement Month 2017 in Russia: hypertension treatment and control-Europe." European heart journal supplements : journal of the European Society of Cardiology vol. 21 (2019): D101-D103. doi: https://doi.org/10.1093/eurheartj/suz068
Rotar O, Konradi A, Tanicheva A, Nakonechnikov S, Blinova N, Beaney T, Xia X, Poulter NR, Chazova I, Shlyakhto E. May Measurement Month 2017 in Russia: hypertension treatment and control-Europe. Eur Heart J Suppl. 2019 Apr;21:D101-D103. doi: 10.1093/eurheartj/suz068. Epub 2019 Apr 24. PMID: 31043892; PMCID: PMC6480026.
Copy Download .nbib Format: NLM
[Debatable questions in chronic heart failure].

Terapevticheskii arkhiv

Chazov EI.
PMID: 8303593
Ter Arkh. 1993;65(9):4-7.

No abstract available.

Cite
Chazov EI. Spornye voprosy v probleme khronicheskoĭ serdechnoĭ nedostatochnosti. [Debatable questions in chronic heart failure]. Ter Arkh. 1993;65(9):4-7
Chazov, E. I. (1993). Spornye voprosy v probleme khronicheskoĭ serdechnoĭ nedostatochnosti. [Debatable questions in chronic heart failure]. Terapevticheskii arkhiv, 65(9), 4-7.
Chazov, E I. "Spornye voprosy v probleme khronicheskoĭ serdechnoĭ nedostatochnosti." [Debatable questions in chronic heart failure]. Terapevticheskii arkhiv vol. 65,9 (1993): 4-7.
Chazov EI. Spornye voprosy v probleme khronicheskoĭ serdechnoĭ nedostatochnosti. [Debatable questions in chronic heart failure]. Ter Arkh. 1993;65(9):4-7. Russian. PMID: 8303593.
Copy Download .nbib Format: NLM
Photonic crystalline IR fibers for the spectral range of 2-40 μm.

Applied optics

Zhukova L, Korsakov A, Chazov A, Vrublevsky D, Zhukov V.
PMID: 22614420
Appl Opt. 2012 May 01;51(13):2414-8. doi: 10.1364/AO.51.002414.

Monocrystals of Ag(1-x)Tl(x)Br(1-x)I(x) and Ag(1-x)Tl(x)Cl(y)I(z)Br(1-y-z) for the spectral range from 2.0 to 40.0 μm with improved photostability were developed and grown. The grown crystals were used for fabrication of single-mode IR fibers. Experimental studies of optical properties of these...

Cite
Zhukova L, Korsakov A, Chazov A, et al. Photonic crystalline IR fibers for the spectral range of 2-40 μm. Appl Opt. 2012;51(13):2414-8doi: 10.1364/AO.51.002414.
Zhukova, L., Korsakov, A., Chazov, A., Vrublevsky, D., & Zhukov, V. (2012). Photonic crystalline IR fibers for the spectral range of 2-40 μm. Applied optics, 51(13), 2414-8. https://doi.org/10.1364/AO.51.002414
Zhukova, Liya, et al. "Photonic crystalline IR fibers for the spectral range of 2-40 μm." Applied optics vol. 51,13 (2012): 2414-8. doi: https://doi.org/10.1364/AO.51.002414
Zhukova L, Korsakov A, Chazov A, Vrublevsky D, Zhukov V. Photonic crystalline IR fibers for the spectral range of 2-40 μm. Appl Opt. 2012 May 01;51(13):2414-8. doi: 10.1364/AO.51.002414. PMID: 22614420.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries